COVID-19 Funding opportunities 

  • As a reminder, conducting on-campus research requires approval during the lock down period.  Click here for more information.
  • For COVID-19 proposal development questions and support, please contact Katie Pizer, BSD Executive Director for Research Administration:  kpizer@bsd.uchicago.edu    
  • To collaborate with other scientists across UChicago and the National Labs who are working on COVID-related research, complete a COVID Faculty Intake Form
  • The BSD Funding Opportunities website lists additional agency, UChicago, and BSD notices and guidelines. 

Last updated: July 30, 2020

AgencyProgramDeadline
Adira FoundationAdira's Fast-Track Grant Response: COVID-19
(Alzheimer’s, ALS, Huntington’s, multiple sclerosis, and Parkinson’s)
Continuous
Biomedical Advanced Research and Development Authority (BARDA) Applied Research to Address The Coronavirus (COVID-19) Emerging Public Health EmergencyRolling; 07/31/2020; 10/31/2020
Biomedical Advanced Research and Development Authority (BARDA) BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency AnnouncementContinuous
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) - includes COVID-19 areas of interestApplications accepted on a rolling basis

Deadline: 10/31/2020
Bloomberg PhilanthropiesCoronavirus Local Response InitiativeContinuous
Chicago Biomedical ConsortiumCBC COVID-19 Response AwardLOI due (required): 7/01/2020

Application: 8/01/2020
CiscoPandemic/COVID19 Science, Technology and Social ImpactRolling
Department of Energy (DOE)Department of Energy (DOE) Invitation for COVID-19 scientific questions:Responses will be reviewed beginning 03/18/2020
Department of Defense (DoD)Request for Information for PPE in response to COVID-19Responses will be reviewed beginning 03/24/2020
Department of Defense (DoD)CDMRP - Clinical Trial AwardPre-Application:
July 29, 2020

Application: August 13, 2020
Defense Logistics AgencyRequest for White Papers: COVID-19 Prototype PPE and Decontamination EquipmentRolling
DFG, German Research FoundationCall for Multidisciplinary Research into Epidemics and Pandemics in Response to the Outbreak of SARS-CoV-2LOI due 07/01/2020; 09/01/2020
Foundation for Opioid Response EffortsStrengthening Access to Care for Opioid Use Disorder Patients During the COVID-19 National Public Health Emergency: Recovery Support Systems07/31/2020
Gilead Sciences, Inc./ Gilean Sciences Pty LtdInvestigator Sponsored Research (ISR) Continuous
GoogleCOVID-19 Related Research credits available from Google Cloud
Research involving the use of patient data, including de-identified data, cannot be considered for this opportunity. Please inform BSD Information Security of your use of Google Cloud resources by emailing: security@bsd.uchicago.edu
Herox, IBM2020 COVID-19 Call for Code Global Challenge07/31/2020
International AIDS SocietyCIPHER Grant ProgramApplications open 10/01/2020
KaggleCOVID-19 Open Research Dataset Challenge (CORD-19)Open
Merck KGaAResearch Grant for Pandemic PreparednessRolling
National Science Foundation (NSF)Rapid Response Research (RAPID) Funding Mechanism
National Science Foundation (NSF)Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)Rapid Proposals; Check with program officers
National Science Foundation (NSF) NSF Rapid Release Funding MechanismRolling
NIH
(This is a limited opportunity which requires an internal selection process.)
NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional)Submit Notification of Interest via InfoReady by 06/26/2020
NIH Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)10/06/2020
NIH Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)LOI due 9/04/2020;
10/05/2020
NIHNotice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel CoronavirusOpen through 04/16/2021
NIHNotice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health DisparitiesOpen through 05/01/2021
NIH – NIANIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)08/03/2020, 09/01/2020, 10/01/2020, 11/02/2020, 12/01/2020, 01/04/2021, 02/01/2021
NIHResearch on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required)03/17/2021
NIHNotice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations09/09/2020
NIHResearch on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed)03/17/2021
NIHEmergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)07/08/2020 (LOI); 08/07/2020 (Final)
NIHNotice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAAOpen through 04/16/2021
NIHNotice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations09/09/2020
NIHEmergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)See Emergency Notice of Special Interest by IC
NIHNotice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations08/07/2020
NIHNotice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)06/22/2020 (Official release); 07/22/2020 (Expected deadline)
NIH - NCI, NIAIDEmergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)07/22/2020
NIH - NCCIH, ORWNotice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19)08/18/2020
NIH, NCINotice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19)08/15/2020
NIH - NIDCDNotice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders09/08/2022
NIH - NIGMSNotice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
2/6/2021
NIH - NCATSNotice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Needmultiple deadlines; see opportunity
NIH - NCATSNotice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)10/17/2020
NIH - NCATSNotice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs11/11/2020
NIH - NCATS Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social SciencesOpen through 04/01/2021
NIH - NCATSEmergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel CoronavirusOpen through 01/26/2022
NIH - NIA and NIMHNotice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)05/01/2021
NIH - NIAID and NIAInvestigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)09/13/2020, 01/13/2021, 05/13/2021, 09/13/2021, 01/13/2022, 05/13/2022
NIH - NIAIDEmergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)Expires 08/14/2020
NIH - NIAIDEmergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)Expires 08/14/2020
NIH - NIAIDNIAID’s Multi-Pronged Response to the COVID-2019 Outbreak
02/06/2021
NIH - NIAID Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)
09/09/2020
NIH - NIEHSNotice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)05/04/2021
NIH - NHLBI Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials08/01/2020
NIH - NIBIB Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)Open through 11/10/2020
NIH - NIBIBNotice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)03/31/2021
NIH - NINDS, NIAAANotice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous SystemOpen Through 04/15/2021
NIH - NIDCRNotice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR11/02/2020
NIH - NCATSNotice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need11/11/2020
NovartisNovartis US COVID-19 InitiativeContinuous
PCORIPhased Large Awards for Comparative Effectiveness Research – Cycle 3 2020 LOI due 09/29/2020; 01/12/2021
Robert Wood Johnson FoundationSystems for Action: Supplemental Research on COVID-19 Response and Recovery08/05/2020
Robert Wood Johnson FoundationPioneering Ideas: Exploring the Future to Build a Culture of HealthContinuous
TD BankThe 2020 TD Ready Challenge08/13/2020
The COVID-19 High Performance Computing (HPC) ConsortiumThe COVID-19 High Performance Computing Consortium Continuous
UK-RAS NetworkMedical Robotics for Contagious Diseases Challenge 202009/30/2020
US ArmyArmy Applications Lab: Call for COVID-19 ProposalsContinuous
US Deparment of State (DOS), US Mission to IndiaCOVID-19 Small Grants Program07/31/2020
Walder FoundationChicago Coronavirus Assessment Network (Chicago CAN)08/03/2020